Global Medical/Diagnostic Imaging Market Size, Share, Opportunities And Trends By Type (X-Ray Imaging Systems, Magnetic Resonance Imaging Systems, Ultrasound Systems, Computerised Tomography Scanners, Nuclear Imaging Systems), By Applications (Cardiovascular, Oncology, Neurology, Gynaecology, Others), By End Users (Hospitals, Diagnostic Centers, Others), And By Geography - Forecasts From 2025 To 2030

Medical/Diagnostic Imaging Market Size:

The Medical/Diagnostic Imaging Market is expected to grow from US$45.240 billion in 2025 to US$57.831 billion in 2030, at a CAGR of 5.03%.

Medical/Diagnostic Imaging Market Trends:

Medical imaging consists of different imaging modalities and processes to image the human body for diagnostic and treatment purposes. A variety of machines and techniques are used to create the pictures of the structures and activities inside your body. The type of imaging techniques used depends on the symptoms and the part of the body to be examined. 

The growth in the medical/diagnostic imaging market may be attributed to the continuous technological advancements in diagnostic imaging modalities. Rising prevalence of chronic diseases such as cancer, cardiovascular, and neurological disorders requiring medical imaging for diagnosis will also have a positive impact on the market growth.

Growth in the number of diagnostic imaging centers will also boost the market for medical/diagnostic imaging during the given forecast period. However, the high cost of medical imaging systems coupled with the rising adoption of refurbished medical imaging devices may hamper the growth of the market during the given time frame.

Major industry players profiled as part of the report are Fujifilm Corporation, Canon Medical Systems Corporation, and Koninklijke Philips N.V,. among others.

Medical/Diagnostic Imaging Market Segmentation:

By Type

X-Ray Imaging Systems

Magnetic Resonance Imaging (MRI) Systems

Ultrasound Systems

Computerised Tomography (CT) Scanners

Nuclear Imaging Systems

By Applications

Cardiovascular

Oncology

Neurology

Gynaecology

Others

 

By End Users

Hospitals

Diagnostic Centers

Others

 

By Geography

North America

United States

Canada

Others

 

South America

Brazil

Argentina

Others

 

Europe

United Kingdom

Germany

France

Others

 

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

 

Asia Pacific

China

India

Australia

South Korea

Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY SOFTWARE

5.1. Introduction

5.2. Standalone Software

5.3. Integrated Software

6. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY IMAGING MODALITY

6.1. Introduction

6.2. X-Ray Imaging

6.3. Magnetic Resonance Imaging (MRI)

6.4. Ultraound Imaging

6.5. Computerised Tomography (CT) Scannig

6.6. Nuclear Imaging

6.7. Others

7. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Diagnostic Centers

7.4. Others

8. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. General Electric Healthcare

10.2. Koninklijke Philips N.V.

10.3. Siemens AG

10.4. Shimadzu Corporation

10.5. Canon Medical Systems Corporation (Canon)

10.6. Carestream Health

10.7. Esaote SpA

10.8. Samsung Healthcare (Samsung)

10.9. Fujifilm Corporation

10.10. Mindray Medical International Limited

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key Benefits for the Stakeholders

11.5. Research Methodology 

11.6. Abbreviations

General Electric Healthcare

Koninklijke Philips N.V.

Siemens AG

Shimadzu Corporation

Canon Medical Systems Corporation (Canon)

Carestream Health

Esaote SpA

Samsung Healthcare (Samsung)

Fujifilm Corporation

Mindray Medical International Limited